Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma
Authors:
- 1 December 2007
- journal article
- Published by Elsevier in Surgical Neurology
- Vol. 68 (6) , 603-608
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- DNA hypermethylation status of multiple genes in soft tissue sarcomasLaboratory Investigation, 2006
- Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic GliomasClinical Cancer Research, 2005
- Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in GlioblastomasJournal of Neuro-Oncology, 2004
- CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alterationCarcinogenesis, 2003
- DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumorsCarcinogenesis, 2003
- Clinical Relevance of MGMT in the Treatment of CancerJournal of Clinical Oncology, 2002
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000
- DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.Journal of Clinical Oncology, 1998
- Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.Journal of Clinical Oncology, 1998
- Low grade supratentorial astrocytomas. Management and prognostic factorsCancer, 1994